Marked clinical overlaps between patients with either anti-LGI1 or anti-CASPR2 antibodies include frequent focal seizures, prominent amnesia, dysautonomia, neuromyotonia, and neuropathic pain (25). Here, LGI1 is linked to dysautonomia.